FMP
agilon health, inc.
AGL
NYSE
agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.
2.89 USD
-0.33 (-11.42%)
Mr. Steven Jackson Sell
Healthcare
Medical - Care Facilities
NYSE
agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.
0001831097
US00857U1079
00857U107
6210 East US Highway 290
562 256 3800
US
1,076
Apr 15, 2021
0001831097
NYSE
Medical - Care Facil...
Healthcare
00857U107
US00857U1079
US
2.89
0.39
6.26M
1.2B
-
1.5-7.73
0
-
-
-
-
-4.66
-
https://agilonhealth.com
Rating Distribution
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Davit Kirakosyan
Nov 11, 2024
JMP Securities analysts shifted their outlook on agilon health (NYSE:AGL), downgrading the company’s rating from Market Outperform to Market Perform. This adjustment followed agilon’s release of its third-quarter financial results for 2024, which revealed performance below expectations. Agilon health reported quarterly revenue of $1.45 billion, a 28% year-over-year increase, though slightly under the $1.47 billion forecast. The company also disclosed an adjusted EBITDA of negative $96 million, w...
Seeking Alpha
Aug 16, 2024
agilon hagilon healthealth shares dropped significantly after disappointing financial results, down 11.9% in two days. The company's revenue surged 38.7% year over year, but its net loss nearly doubled, and guidance for 2024 is mixed. Concerns include declining cash reserves, potential for further dilution, and uncertainty regarding share valuation.
Seeking Alpha
Aug 6, 2024
Magilon health, inc. (NYSE:AGL ) Q2 2024 Earnings Conference Call August 6, 2024 4:30 PM ET Company Participants Leland Thomas - VP, IR Steven Sell - CEO Jeffrey Schwaneke - CFO Conference Call Participants Lisa Gill - JPMorgan Justin Lake - Wolfe Research Stephen Baxter - Wells Fargo Ryan Daniels - William Blair Elizabeth Anderson - Evercore ISI Adam Ron - Bank of America.
Zacks Investment Research
Aug 6, 2024
While the top- and bottom-line numbers for Agilon (AGL) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Zacks Investment Research
Aug 6, 2024
Agilon Health (AGL) came out with a quarterly loss of $0.07 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.04 per share a year ago.
Zacks Investment Research
May 7, 2024
Although the revenue and EPS for Agilon (AGL) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Business Wire
Apr 16, 2024
AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the first quarter 2024 after the market closes on Tuesday, May 7, 2024, and host a conference call at 4:30 PM Eastern Time the same day to discuss the results. The conference call can be accessed by dialing (833) 470-1428 for U.S. participants and +1 (929) 526-1599 for international partic.
Zacks Investment Research
Mar 25, 2024
T, AGL and ALTO have been added to the Zacks Rank #5 (Strong Sell) List on March 25, 2023.